Treatment of local recurrence of esophageal cancer following Ivor‐Lewis esophagectomy—Experiences of a high‐volume center
World Journal of Surgery · 2024
DOI: 10.1002/wjs.12169 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, 2024. Verfasst von Karl Knipper und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and University Hospital of Cologne, Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophagectomy, Neoplasm Recurrence, Local, Hospitals, High-Volume. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität zu Köln.
Abstract (Originalsprache)
Purpose
Patients with local recurrence of esophageal cancer have a highly decreased overall survival. There is currently no standardized treatment algorithm for this group. This retrospective cohort study aimed to evaluate the survival of patients with local recurrence, despite receiving individualized treatment options.
Methods
241 of 1791 patients were diagnosed with a local recurrence following Ivor‐Lewis esophagectomy at the University Hospital of Cologne. 59 patients, who were diagnosed only with a local recurrence of adeno‐ or squamous cell carcinoma and received their individualized therapy regimes at our high‐volume center, were included.
Results
The study included 52 patients with adenocarcinoma and 7 with squamous cell carcinoma. Among these, 6 patients underwent resection, 19 received solely chemotherapy, 29 received chemoradiotherapy, and 5 were provided with best supportive care. Patients who underwent resection showed a better survival outcome compared to patients without resection (median OS: not reached vs. 15.1 months, p = 0.012). Best supportive care and palliative care were found to be independent risk factors for shorter overall survival compared to curative intended treatment options like local resection or chemoradiotherapy.
Conclusion
In this study, different treatment strategies for patients with local recurrence of esophageal cancer were depicted. Resection as well as chemoradiotherapy could play a role in selected patients. Further prospective studies are needed to improve the selection of eligible patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and University Hospital of Cologne, Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany.
- Faculty of Medicine and University Hospital of Cologne, Institute of Pathology, University of Cologne, Cologne, Germany.
- Faculty of Medicine and University Hospital of Cologne, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
ORCID-Profile: Karl Knipper
Förderung
- Universität zu Köln
Zitieren
APA
Knipper, K., Krey, T., Lyu, S. I., Jung, J. O., Wirsik, N. M., Fuchs, H. F., Schröder, W., Schlößer, H. A., Popp, F. C., Quaas, A., Bruns, C. J., & Schmidt, T. (2024). Treatment of local recurrence of esophageal cancer following Ivor‐Lewis esophagectomy—Experiences of a high‐volume center. World Journal of Surgery. https://doi.org/10.1002/wjs.12169
Vancouver
Knipper K, Krey T, Lyu SI, Jung JO, Wirsik NM, Fuchs HF, et al. Treatment of local recurrence of esophageal cancer following Ivor‐Lewis esophagectomy—Experiences of a high‐volume center. World Journal of Surgery. 2024. doi:10.1002/wjs.12169
BibTeX
@article{Knipper2024,
author = {Knipper, Karl and Krey, Thaddaeus and Lyu, Su Ir and Jung, Jin-On and Wirsik, Naita M and Fuchs, Hans F and Schröder, Wolfgang and Schlößer, Hans A and Popp, Felix C and Quaas, Alexander and Bruns, Christiane J and Schmidt, Thomas},
title = {Treatment of local recurrence of esophageal cancer following Ivor‐Lewis esophagectomy—Experiences of a high‐volume center},
journal = {World Journal of Surgery},
year = {2024},
doi = {10.1002/wjs.12169}
}
EUVIMED